project name: European Network For The Study Of Adrenal Tumours - Structuring Clinical Research On Adrenal Cancers In Adults
Framework Programme: FP7 programme area: Health
contract/proposal/call number: 259735
status: active
start date: January 2011 duration: 60 months projected finish date: January 2016
total budget: € 7,994,054
Note that the follow people may not represent the full extent of the consortium. FEAST has tried to identify the Australian participants, and their collaborators (or coordinator), within the project. Also note that Australian participation may not necessarily be on a formal level. Further details about the partners in this project can be found at the website listed below.
| name | organisation | state or country |
|---|---|---|
| LMU | Germany | |
| The University of Melbourne | VIC, Australia |
WWW: cordis.europa.eu/search/index.cfm?fuseaction=proj.document&PJ_RCN=11770970
summary:
Among patients with adrenal masses Adrenocortical carcinoma (ACC) and malignant pheochromocytomas (MPH) are found with a low incidence but very unfavorable prognosis. Due to this poor clinical outcome, concomitant hormone dysregulation and limited treatment options the two cancer entities severely impact on affected patients. However, the rarity of the tumours also impedes clinical studies which are affected by fragmentation and low cohort sizes. The European Network for the Study of Adrenal Tumours (ENS@T) has recently implemented a collection of adrenal tumour related databases and defined an associated network of Biological Resource Centers devoted to research on adrenal tumours. The concurrence of recent achievements of this evolving network, the progress in the understanding of molecular mechanisms and increasing availability of specific diagnostic and therapeutic tools for adrenal cancers provides the unique opportunity to achieve unmatched progress in the implementation of both translation and clinical research dedicated to ACC and MPH.